ACE2 and diabetic kidney disease: As shown in Figure 6A, we analysed single‐podocyte ACE2 expression in 13 different biopsies of patients diagnosed for FSGS (primary and secondary), diabetic nephropathy (DN), membranous nephropathy (MN), Lupus nephritis (LN), IgA nephropathy, ANCA‐positive glomerulonephritis and Goodpasture syndrome.